utero, fetal bilirubin is cleared by the placenta. At birth the neonatal liver must assume detoxification and elimination of bilirubin. The mechanisms responsible for development of bilirubin conjugation after birth are poorly understood. Evidence for substrate-dependent stimulation of bilirubin conjugation in heterozygous newborn Gunn rats has been reported by Thaler (8) but studies of bilirubin conjugation in human neonates have not been performed due to unavailability of adequate methods. The gestation age at which the capacity for bilirubin conjugation is acquired and the types of conjugates initially formed are unknown. A highly specific and sensitive method for the measurement of unconjugated bilirubin and bilirubin mono-and diester conjugates in biologic fluids has been developed in our laboratory (9, 10). By utilizing this procedure, we investigated the appearance of bilirubin conjugates in serum of human neonates during the period of physiologic jaundice.
neonatal liver must assume detoxification and elimination of bilirubin. The mechanisms responsible for development of bilirubin conjugation after birth are poorly understood. Evidence for substrate-dependent stimulation of bilirubin conjugation in heterozygous newborn Gunn rats has been reported by Thaler (8) but studies of bilirubin conjugation in human neonates have not been performed due to unavailability of adequate methods. The gestation age at which the capacity for bilirubin conjugation is acquired and the types of conjugates initially formed are unknown. A highly specific and sensitive method for the measurement of unconjugated bilirubin and bilirubin mono-and diester conjugates in biologic fluids has been developed in our laboratory (9, 10) . By utilizing this procedure, we investigated the appearance of bilirubin conjugates in serum of human neonates during the period of physiologic jaundice.
Collection of serum specimens. Forty-three serial serum samples obtained in the course of routine laboratory evaluation from 13 premature infants (six male, seven female) of 25-36 wk gestational age were compared with 25 samples from 11 fullterm newborns (six male, five female) of 37-41 wk gestational age during the first 3 days oflife. Birth weights for the premature infant group ranged from 590-3000 g while full-term infant's birth weights ranged between 2500-3900 g. Infants with evidence of hemolysis or liver disease were excluded from the study.
For comparison, serum samples from 22 healthy adults, seven pregnant women at term and their corresponding infant's cord blood at delivery, 46 cord blood specimens obtained at unselected deliveries, and five cord blood specimens from neonates with intrauterine hyperbilirubinemia due to blood group incompatibility or hypoxia also were examined.
All specimens were protected from light in containers wrapped in aluminum foil, and were assayed immediately or after storage in the light-shielded containers at -12°C for less than I wk.
Analytical methods. All procedures were performed in dim light. The AM-HPLC method for analysis of serum bilirubins has been previously described (9, 10) . About 60 mg of sodium ascorbate, 2-3 mg of disodium ethylene diamine tetraacetate, 4 ml of methanol, and 2 ml of methanol containing the internal standard xanthobilirubic acid methyl ester were mixed with 0.6 ml of serum. The mixture was treated with 6 ml of 2% (w/v) KOH in methanol and immediately vortex-mixed. After reaction for 60-90 s at 20-25°C, 6 ml of chloroform and 12 ml of g1ycine/ HCI buffer (004 M HCI brought to pH 204 with solid glycine) were added sequentially. Organic and aqueous phases were separated by brief centrifugation, the organic phase was transferred to a dry tube, and the extract evaporated to dryness under nitrogen at 30°C. The residue was stored under argon at -12°C and analyzed within I wk. 947 Abbreviation AM-HPLC, alkaline methanolysis-high-performance liquid chromatography ABSTRACf. Bilirubin conjugates in the serum of newborn human infants were investigated using the alkaline methanolysis-high-performance liquid chromatography method, a specific and sensitive method for measurement of unconjugated bilirubin and bilirubin mono-and diester conjugates. Serum samples were analyzed from 13 premature infants, 11 full term newborns, 22 healthy adults, seven pregnant women at term and their corresponding infants cord blood at delivery, 46 cord blood specimens obtained at unselected deliveries, three cord bloods from infants with maternal-fetal blood group incompatibility, and two cord bloods from infants with intrauterine hypoxia. Bilirubin conjugates were not detectable in the healthy adults, maternal blood, or in the cord blood specimens except from infants with blood group incompatibility or intrauterine hypoxia. The two isomeric monoconjugates of bilirubin appeared in serum during the first 24 to 48 postnatal h in both premature and full term infants, followed by the diconjugate on the 3rd day. Conjugated esters accounted for 2 to 5% of the total bilirubin, with the diconjugate constituting 21 % of total conjugated pigment (day 3). In all instances, the unconjugated serum bilirubin concentration had increased to at least 2 mg/dl in the course of physiologic neonatal hyperbilirubinemia before bilirubin conjugates became detectable. Both premature and full term human infants displayed the identical pattern of bilirubin conjugation in serum. (Pediatr Res 20:947-950, 1986) Physiologic jaundice refers to the transient hyperbilirubinemia which normally develops during the first 3 to 5 days after birth in the human newborn infant (1,2). This process is presumed to reflect maturational deficiency of bilirubin g1ucuronyl transferase (UDP glucuronate ,B-g1ucuronosyl transferase EC 204.1.17), the enzyme system responsible for bilirubin conjugation (3) . Studies in animals have demonstrated that bilirubin g1ucuronyl transferase activity is undetectable in fetal liver, but increases after birth at rates which exhibit considerable species variability (4-7). In
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The pigment residue obtained from alkaline methanolysis was redissolved in 100 JlI of chloroform and 25 JlI of the solution injected in the liquid chromatograph. Pigment separation, peak assignment, and calculation ofresults were obtained as previously reported (9, 10) . The methodology employed measured bilirubin in serum down to 0.01 mg/IOO ml with an accuracy of5% (10) .
All reagents were purchased from commercial sources and were analytical-reagent grade. The internal standard, crystalline methyl ester of xanthobilirubic acid was prepared as described by Grunewald et al. (11) .
For statistical analysis the Student's t test was used; p ::5 0.05 was considered to be significant.
RESULTS
Mean total serum bilirubin values in healthy adults, pregnant women at term and their corresponding infant's cord blood, and unselected cord bloods from uncomplicated deliveries are presented in Figure 1 . Of significance, the total bilirubin consisted entirely of unconjugated pigment by this method. The difference observed between the bilirubin concentration in serum of pregnant women at term and in cord blood serum from each corresponding infant was highly significant (p < 0.001). In contrast, cord blood samples from the blood group incompatible and intrauterine hypoxic infants contained unconjugated bilirubin in concentration >2 mg/dl and esterified bilirubins were detectable in these samples (Fig. 2) .
During the first 3 days of life, serum from premature and fullterm newborn human infants contained measurable amounts of esterified bilirubin as seen in Figures 3 and 4 . Monoesters of bilirubin appeared during the first 24 to 48 h after birth, and the diester followed on the 3rd day increasing to 21 % of the total esters. The C-8 monoester was the predominant bilirubin conjugate fraction observed. In premature infants mean total serum bilirubin values were 3.3 ± 1.8 (SD) for day 1,4.2 ± 2.3 for day 2, and 3.3 ± 2.1 mg/dl for day 3. In full-term infants mean total serum bilirubin values were 2.9 ± 2 for day 1,4.2 ± 1.9 for day 2, and 4.9 ± 1.4 mg/dl for day 3. In all instances, the serum bilirubin concentration reached at least 2 mg/dl before bilirubin esters became detectable in the infant's serum. The entire conjugated fraction (monoconjugates plus diconjugate) accounted for 2 to 5% of the total bilirubin value. The fraction of the total bilirubin represented by conjugates remained constant during the 3 days studied. Bilirubin esterS were detected in the serum samples ofa premature infant of only 25 wk gestation. In general, bilirubin conjugate levels were higher in the serum of full-term infants than premature infants (Figs. 3 and 4) . become detectable. In the rat, unconjugated bilirubin stimulates bilirubin UDP-glucuronosyltransferase activity and thereby induces its own conjugation with glucuronide (8, 13) . The observations in the human newborn infants and in the cord blood samples from infants with prenatal hyperbilirubinemia are consistent with the findings in rats and suggests that bilirubin may participate in inducing its own conjugation during the perinatal period.
Defective transport of bile acids in early life has been suggested by studies demonstrating elevated serum bile acid concentrations, impaired bile acid uptake, and impaired transport and excretion of organic anions by animals and human infants (14) (15) (16) ). The present study shows that the ratio ofbilirubin conjugates to the total bilirubin value remains constant during the period of physiologic jaundice. With cholestasis, the conjugated fraction of serum bilirubin would be expected to increase. This finding suggests that accumulation of conjugated bilirubins is not a significant component of physiologic jaundice and differs from the bile acid observations. The bilirubin data are consistent with immature enzyme activity rather than impaired transport of conjugated bilirubin.
The detection of monoconjugated forms of bilirubin prior to the detection of diconjugated bilirubin suggests a possible transition from an immature to a mature enzyme system for bilirubin conjugation. Maturation of conjugation appears to favor formation of monoconjugates initially. This may be advantageous to the newborn since the potentially toxic unconjugated bilirubin that is accumulating becomes water soluble when converted to the monoconjugate form and mOre readily disposable in bile. Further, the process is efficient since only one sugar molecule is utilized for each bilirubin molecule.
In summary, bilirubin conjugation can occur prematurely in utero in infants with prenatal hyperbilirubinemia. Serum unconjugated bilirubin concentrations greater than 2 mg/dl appear to be a prerequisite for formation of bilirubin conjugates in human neonates. Bilirubin conjugation in both premature and full-term infants displays a similar pattern of conjugation with monoconjugates appearing prior to the diconjugate. While other studies are needed to further elucidate the mechanisms responsible for bilirubin conjugation in the human newborn, it appears that bilirubin may playa fundamental role in initiation of bilirubin conjugation after birth. 
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DISCUSSION
Cord blood is normally devoid of conjugated bilirubin. In utero, the placenta clears the unconjugated bilirubin produced by the fetus. Cord blood contains bilirubin in a concentration four times higher than in maternal serum. Thus, the gradient of bilirubin flow is from fetus to mother. In contrast with normal newborns, infants with prenatal hyperbilirubinemia are capable offorming bilirubin conjugates in utero. Concentrations ofdirect reacting pigment up to 10 mg/dl have been found in the gallbladders of such fetuses (12) . These data indicate that bilirubin UDP-glucuronosyl-transferase activity can be prematurely induced in utero in the presence of chronically elevated concentrations of the pigment substrate.
After birth, with cessation of placental function, the neonatal liver must assume bilirubin conjugating activity. In both premature and full-term infants conjugation begins in a distinct sequence. Monoconjugated bilirubin appears in the serum during the first 24 to 48 h. Diconjugated esters follow thereafter. These findings suggest that bilirubin conjugation is normally initiated in both premature and full-term infants as physiologic jaundice develops during the first days of life. When total serum bilirubin levels rise to levels >2 mg/dl after birth, bilirubin conjugates
